Characteristics, Trends, and Outcomes of Intravascular Lithotripsy-Assisted Transfemoral Transcatheter Aortic Valve Replacement in United States

Document Type

Article

Publication Date

10-28-2024

Publication Title

JACC Cardiovasc Interv

Abstract

BACKGROUND: Transfemoral (TF) access is the preferred approach for transcatheter aortic valve replacement (TAVR). Limited data exist regarding the outcomes of intravascular lithotripsy (IVL)-assisted TF TAVR in patients with peripheral artery disease.

OBJECTIVES: This study sought to examine contemporary characteristics, trends, and outcomes of IVL TAVR in the United States.

METHODS: The Vizient Clinical Database was queried for patients who underwent percutaneous TAVR between October 1, 2020, and November 30, 2023. Outcomes with IVL TAVR vs non-IVL TAVR were examined after propensity score matching. The primary outcome was a composite of in-hospital death, stroke, vascular complications, surgical vascular intervention, and major bleeding.

RESULTS: Over the study period, 129,655 patients (mean age of 78.4 years, 42.2% women, 87.1% White) underwent percutaneous TAVR at 361 hospitals, 1,242 (0.96%) of whom underwent IVL TAVR. There was an uptrend in IVL TAVR, but the frequency remained low. IVL TAVR patients had a higher median Elixhauser comorbidity score (5 [Q1-Q3: 4-7] vs 4 [Q1-Q3: 3-6]) compared to non-IVL TAVR. TAVR was completed via the TF approach in 1,238 (99.7%) IVL TAVR patients. In a 3:1 propensity score matching analysis, IVL TAVR was associated with a higher rate of the primary composite outcome (21.9% vs 13.7%; P < 0.001) driven by higher rates of vascular complications, surgical vascular intervention, and major bleeding. In-hospital death and stroke were similar in both groups.

CONCLUSIONS: In the United States, IVL is increasingly adopted to facilitate TF TAVR. IVL TAVR patients exhibited a higher burden of comorbidities and experienced more complications compared to non-IVL TAVR patients. Further studies are needed to identify appropriate anatomical and clinical use criteria for IVL TAVR and to compare its outcomes vs alternative non-TF TAVR.

Medical Subject Headings

Humans; Transcatheter Aortic Valve Replacement; Female; Male; Aged; Aged, 80 and over; Treatment Outcome; United States; Femoral Artery; Risk Factors; Aortic Valve Stenosis; Databases, Factual; Time Factors; Hospital Mortality; Catheterization, Peripheral; Lithotripsy; Risk Assessment; Retrospective Studies; Punctures; Aortic Valve; Peripheral Arterial Disease; Postoperative Complications

PubMed ID

39477639

Volume

17

Issue

20

First Page

2367

Last Page

2376

Find It @ Sladen

Share

COinS